ScreenPoint Medical is a Dutch company founded in 2014 by Professors Nico Karssemeijer and Mike Brady. Pioneers in their field, they assembled a team of experts in breast imaging and artificial intelligence to develop a decision support algorithm. The team’s ultimate goal is to facilitate early detection of breast cancer, improving survival rates and enabling earlier treatment with less invasive methods.